Cochrane Abstracts
Drug treatment for spinal muscular atrophy type I
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Drug Treatment for Spinal Muscular Atrophy Type I." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439325/all/Drug_treatment_for_spinal_muscular_atrophy_type_I.
Drug treatment for spinal muscular atrophy type I. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439325/all/Drug_treatment_for_spinal_muscular_atrophy_type_I. Accessed December 5, 2024.
Drug treatment for spinal muscular atrophy type I. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439325/all/Drug_treatment_for_spinal_muscular_atrophy_type_I
Drug Treatment for Spinal Muscular Atrophy Type I [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439325/all/Drug_treatment_for_spinal_muscular_atrophy_type_I.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Drug treatment for spinal muscular atrophy type I
ID - 439325
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439325/all/Drug_treatment_for_spinal_muscular_atrophy_type_I
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
